References
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:https://doi.org/10.3322/caac.21492.
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. doi:https://doi.org/10.3322/caac.21442.
- Tohme S, Simmons RL, Tsung A. Surgery for cancer: a trigger for metastases. Cancer Res. 2017;77(7):1548–1552. doi:https://doi.org/10.1158/0008-5472.CAN-16-1536.
- Chen Z, Zhang P, Xu Y, Yan J, Liu Z, Lau WB, et al. Surgical stress and cancer progression: the twisted tango. Mol Cancer. 2019;18(1):132. doi:https://doi.org/10.1186/s12943-019-1058-3.
- Oosterling SJ, van der Bij GJ, Meijer GA, Tuk CW, van Garderen E, van Rooijen N, et al. Macrophages direct tumour histology and clinical outcome in a colon cancer model. J Pathol. 2005;207(2):147–155. doi:https://doi.org/10.1002/path.1830.
- Horowitz M, Neeman E, Sharon E, Ben-Eliyahu S. Exploiting the critical perioperative period to improve long-term cancer outcomes. Nat Rev Clin Oncol. 2015;12(4):213–226. doi:https://doi.org/10.1038/nrclinonc.2014.224.
- Tohme S, Yazdani HO, Al-Khafaji AB, Chidi AP, Loughran P, Mowen K, et al. Neutrophil extracellular traps promote the development and progression of liver metastases after surgical stress. Cancer Res. 2016;76(6):1367–1380. doi:https://doi.org/10.1158/0008-5472.CAN-15-1591.
- Duan X, Zhu Y, Cui Y, Yang Z, Zhou S, Han Y, et al. Circulating tumor cells in the pulmonary vein increase significantly after lobectomy: a prospective observational study. Thorac Cancer. 2019;10(2):163–169. doi:https://doi.org/10.1111/1759-7714.12925.
- Yamaguchi K, Takagi Y, Aoki S, Futamura M, Saji S. Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg. 2000;232(1):58–65.
- Bates GJ, Fox SB, Han C, Leek RD, Garcia JF, Harris AL, Banham AH. Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. JCO. 2006;24(34):5373–5380. doi:https://doi.org/10.1200/JCO.2006.05.9584.
- Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med. 2004;10(9):942–949. doi:https://doi.org/10.1038/nm1093.
- Ichihara F, Kono K, Takahashi A, Kawaida H, Sugai H, Fujii H. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin Cancer Res. 2003;9(12):4404–4408.
- Zheng X, Dong L, Wang K, Zou H, Zhao S, Wang Y, Wang G. MiR-21 participates in the PD-1/PD-L1 pathway-mediated imbalance of Th17/Treg cells in patients after gastric cancer resection. Ann Surg Oncol. 2019;26(3):884–893. doi:https://doi.org/10.1245/s10434-018-07117-6.
- Dong L, Zheng X, Wang K, Wang G, Zou H. Programmed death 1/programmed cell death-ligand 1 pathway participates in gastric surgery-induced imbalance of T-helper 17/regulatory T cells in mice. J Trauma Acute Care Surg. 2018;85(3):549–559. doi:https://doi.org/10.1097/TA.0000000000001903.
- Sun Z, Du C, Xu P, Miao C. Surgical trauma-induced CCL18 promotes recruitment of regulatory T cells and colon cancer progression. J Cell Physiol. 2019;234(4):4608–4616. doi:https://doi.org/10.1002/jcp.27245.
- Griffith JW, Sokol CL, Luster AD. Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol. 2014;32:659–702. doi:https://doi.org/10.1146/annurev-immunol-032713-120145.
- Sarvaiya PJ, Guo D, Ulasov I, Gabikian P, Lesniak MS. Chemokines in tumor progression and metastasis. Oncotarget. 2013;4(12):2171–2185. doi:https://doi.org/10.18632/oncotarget.1426.
- Zhang J, Lu Y, Pienta KJ. Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth. J Natl Cancer Inst. 2010;102(8):522–528. doi:https://doi.org/10.1093/jnci/djq044.
- Wang T, Zhan Q, Peng X, Qiu Z, Zhao T. CCL2 influences the sensitivity of lung cancer A549 cells to docetaxel. Oncol Lett. 2018;16(1):1267–1274. doi:https://doi.org/10.3892/ol.2018.8769.
- Zhao H, Li L, Zhang J, Zheng C, Ding K, Xiao H, et al. C-C chemokine ligand 2 (CCL2) recruits macrophage-membrane-camouflaged hollow bismuth selenide nanoparticles to facilitate photothermal sensitivity and inhibit lung metastasis of breast cancer. ACS Appl Mater Interfaces. 2018;10(37):31124–31135. doi:https://doi.org/10.1021/acsami.8b11645.
- Chang AL, Miska J, Wainwright DA, Dey M, Rivetta CV, Yu D, et al. CCL2 produced by the glioma microenvironment is essential for the recruitment of regulatory T cells and myeloid-derived suppressor cells. Cancer Res. 2016;76(19):5671–5682. doi:https://doi.org/10.1158/0008-5472.CAN-16-0144.
- Buvanendran A, Kroin JS, Kerns JM, Nagalla SN, Tuman KJ. Characterization of a new animal model for evaluation of persistent postthoracotomy pain. Anesth Analg. 2004;99(5):1453–1460.
- Wang H, Liu W, Cai Y, Ma L, Ma C, Luo A, Huang Y. Glutaminase 1 is a potential biomarker for chronic post-surgical pain in the rat dorsal spinal cord using differential proteomics. Amino Acids. 2016;48(2):337–348. doi:https://doi.org/10.1007/s00726-015-2085-z.
- Coffey JC, Wang JH, Smith MJ, Bouchier-Hayes D, Cotter TG, Redmond HP. Excisional surgery for cancer cure: therapy at a cost. Lancet Oncol. 2003;4(12):760–768. doi:https://doi.org/10.1016/S1470-2045(03)01282-8.
- Li W, Wu K, Zhao E, Shi L, Li R, Zhang P, et al. HMGB1 recruits myeloid derived suppressor cells to promote peritoneal dissemination of colon cancer after resection. Biochem Biophys Res Commun. 2013;436(2):156–161. doi:https://doi.org/10.1016/j.bbrc.2013.04.109.
- Lee JW, Shahzad MM, Lin YG, Armaiz-Pena G, Mangala LS, Han HD, et al. Surgical stress promotes tumor growth in ovarian carcinoma. Clin Cancer Res. 2009;15(8):2695–2702. doi:https://doi.org/10.1158/1078-0432.CCR-08-2966.
- Tang F, Tie Y, Tu C, Wei X. Surgical trauma-induced immunosuppression in cancer: Recent advances and the potential therapies. Clin Transl Med. 2020;10(1):199–223. doi:https://doi.org/10.1002/ctm2.24.
- Ogawa K, Hirai M, Katsube T, Murayama M, Hamaguchi K, Shimakawa T, et al. Suppression of cellular immunity by surgical stress. Surgery. 2000;127(3):329–336. doi:https://doi.org/10.1067/msy.2000.103498.
- Shakhar G, Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients? Ann Surg Oncol. 2003;10(8):972–992. doi:https://doi.org/10.1245/aso.2003.02.007.
- Phillips JD, Knab LM, Blatner NR, Haghi L, DeCamp MM, Meyerson SL, Heiferman MJ, et al. Preferential expansion of pro-inflammatory Tregs in human non-small cell lung cancer. Cancer Immunol Immunother. 2015;64(9):1185–1191. doi:https://doi.org/10.1007/s00262-015-1725-1.
- Wolf AM, Wolf D, Steurer M, Gastl G, Gunsilius E, Grubeck-Loebenstein B. Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res. 2003;9(2):606–612.
- Saito Y, Shimada M, Utsunomiya T, Morine Y, Imura S, Ikemoto T, et al. Regulatory T cells in the blood: a new marker of surgical stress. Surg Today. 2013;43(6):608–612. doi:https://doi.org/10.1007/s00595-013-0517-5.
- Decker T, Fischer G, Bucke W, Bucke P, Stotz F, Gruneberger A, et al. Increased number of regulatory T cells (T-regs) in the peripheral blood of patients with Her-2/neu-positive early breast cancer. J Cancer Res Clin Oncol. 2012;138(11):1945–1950. doi:https://doi.org/10.1007/s00432-012-1258-3.
- Albertsmeier M, Quaiser D, von Dossow-Hanfstingl V, Winter H, Faist E, Angele MK. Major surgical trauma differentially affects T-cells and APC. Innate Immun. 2015;21(1):55–64. doi:https://doi.org/10.1177/1753425913516659.
- Lissoni P, Brivio F, Fumagalli L, Messina G, Meregalli S, Porro G, et al. Effects of the conventional antitumor therapies surgery, chemotherapy, radiotherapy and immunotherapy on regulatory T lymphocytes in cancer patients. Anticancer Res. 2009;29(5):1847–1852.
- Xu P, He H, Gu Y, Wang Y, Sun Z, Yang L, Miao C. Surgical trauma contributes to progression of colon cancer by downregulating CXCL4 and recruiting MDSCs. Exp Cell Res. 2018;370(2):692–698. doi:https://doi.org/10.1016/j.yexcr.2018.07.035.
- Okabe H, Tsunoda S, Tanaka E, Hisamori S, Mizumoto M, Murakami K, Sakai Y. Advantages and pitfalls of minimally invasive surgery for esophagogastric junction tumors. Nihon Geka Gakkai Zasshi. 2015;116(1):45–49.
- Zhang LB, Wang B, Wang XY, Zhang L. Influence of video-assisted thoracoscopic lobectomy on immunological functions in non-small cell lung cancer patients. Med Oncol. 2015;32(7):201. doi:https://doi.org/10.1007/s12032-015-0639-2.
- Reck M, Heigener DF, Mok T, Soria JC, Rabe KF. Management of non-small-cell lung cancer: recent developments. Lancet. 2013;382(9893):709–719. doi:https://doi.org/10.1016/S0140-6736(13)61502-0.
- Pasparakis M, Vandenabeele P. Necroptosis and its role in inflammation. Nature. 2015;517(7534):311–320. doi:https://doi.org/10.1038/nature14191.
- Liang H, Deng L, Hou Y, Meng X, Huang X, Rao E, et al. Host STING-dependent MDSC mobilization drives extrinsic radiation resistance. Nat Commun. 2017;8(1):1736. doi:https://doi.org/10.1038/s41467-017-01566-5.